0001209191-14-052238.txt : 20140813
0001209191-14-052238.hdr.sgml : 20140813
20140813174829
ACCESSION NUMBER: 0001209191-14-052238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140811
FILED AS OF DATE: 20140813
DATE AS OF CHANGE: 20140813
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flannelly Barry P
CENTRAL INDEX KEY: 0001615842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 141038748
MAIL ADDRESS:
STREET 1: ROUTE 141 AND HENRY CLAY ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-08-11
0
0000879169
INCYTE CORP
INCY
0001615842
Flannelly Barry P
EXPERIMENTAL STATION
ROUTE 141 & HENRY CLAY ROAD
WILMINGTON
DE
19880
0
1
0
0
See Remarks
Incentive Stock Option (right to buy)
48.44
2014-08-11
4
A
0
6192
0.00
A
2021-08-10
Common Stock
6192
6192
D
Non-Qualified Stock Options (right to buy)
48.44
2014-08-11
4
A
0
42218
0.00
A
2021-08-10
Common Stock
42218
42218
D
Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Exec VP, Bus Dev and Strategic Planning
/s/ Barry P. Flannelly
2014-08-13